Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NantHealth
Biotech
Sorrento sues Soon-Shiong over cancer drug 'catch-and-kill'
Sorrento alleged Patrick Soon-Shiong bought its cancer med Cynviloq to stop the drug from getting to market and competing with Celgene's Abraxane.
Amirah Al Idrus
Apr 3, 2019 6:37pm
Soon-Shiong planning IPO for cancer vaccine subsidiary: report
Jun 11, 2018 10:20am
NantHealth cuts staff, offloads assets as Q2 losses hit $70M
Aug 11, 2017 7:53am
Soon-Shiong deal for Altor could be rocked by revolt
Jun 28, 2017 7:48am
Despite 'looting' claims, Soon-Shiong’s NantCell to buy Altor
Jun 27, 2017 8:43am
Chutes & Ladders—Scott Gottlieb confirmed as FDA commissioner
May 11, 2017 7:02pm
